R&D

The setting up of a separate Department of Biotechnology (DBT), under the Ministry of Science and Technology in 1986 gave a new impetus to the development of the field of modern biology and biotechnology in India. In more than a decade of its existence, the department has promoted and accelerated the pace of development of biotechnology in the country. Through several R&D projects, demonstrations and creation of infrastructural facilities a clear visible impact of this field has been seen.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India.

The Department of Biotechnology (DBT), Govt. of India has initiated a multi-institutional partnership program on biodesign called the National Biodesign Alliance Programme between Translational Health Science & Technology Institute (THSTI), Regional Centre for Biotechnology (RCB), International Centre for Genetic Engineering and Biotechnology (ICGEB), All India Institute of Medical Sciences (AIIMS), Indian Institute of Technology (IIT) Delhi, IIT Chennai and Christian Medical College (CMC) Vellore.

TotipotentRX Cellular Medicine™ is a private company based in Los Angeles and New Delhi having experience in developing, licensing, managing, and publishing pre-clinical and early phase human clinical trials specific to the use of autologous and allogeneic cells for regenerative medicine applications, including the healing of damaged tissues and/or organs.

Applications are invited for appointment on contractual basis for two post of National Consultant (IDD) under the National Iodine Deficiency Disorders Control Programme by the Nutrition & IDD Cell of the Directorate General of Health Services, Ministry of Health & Family Welfare, Govt, of India, New Delhi. The details for aforesaid post are as follows:-

A Public Limited Company in the Business of Manufacturing & Marketing of APIs and Drug Intermediates with an Annual Turnover of about Rs.70 Crores with a significant presence in the international market.

Post: Research Associate

[adsense:336x280:8701650588]

Bristol-Myers Squibb Biocon R&D Center (BBRC) is a collaboration between Bristol-Myers Squibb and Syngene International, a subsidiary of the Indian biotechnology major, Biocon. This initiative is intended to help advance Bristol-Myers Squibb's work in discovery and early drug development. The center is expanding its capabilities to clinical biomarkers, toxicology and first-in-human studies.